Login / Signup

A new rapid titration protocol for lamotrigine that reduces the risk of skin rash.

Yoonhyuk JangJangsup MoonNarae KimTae-Joon KimJin-Sun JunYong-Won ShinHyeyeon ChangHye-Ryun KangSoon Tae LeeKeun-Hwa JungKyung-Il ParkKi-Young JungKon ChuSang Kun Lee
Published in: Epilepsia open (2021)
These findings demonstrate the value of the novel tolerance induction protocol for lamotrigine, which could widen the available application of lamotrigine in various situations. However, this study is a preliminary study limited by a small number of patients and its nonrandomized and open-label design, so the current protocol needs more rigorous clinical evaluations before the application to the real clinical setting.
Keyphrases
  • randomized controlled trial
  • end stage renal disease
  • open label
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • clinical trial
  • prognostic factors
  • peritoneal dialysis
  • study protocol
  • quantum dots